Cargando…
Synthesized OVA(323-339)MAP octamers mitigate OVA-induced airway inflammation by regulating Foxp3 T regulatory cells
BACKGROUND: Antigen-specific immunotherapy (SIT) has been widely practiced in treating allergic diseases such as asthma. However, this therapy may induce a series of allergic adverse events during treatment. Peptide immunotherapy (PIT) was explored to overcome these disadvantages. We confirmed that...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472185/ https://www.ncbi.nlm.nih.gov/pubmed/22769043 http://dx.doi.org/10.1186/1471-2172-13-34 |